Highlights Sandoz Group AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:30:12 2024-05-24 EDT			5-day change	1st Jan Change
32.02 ^CHF	-0.93%		-0.77%	+18.33%

05-22	Sandoz: Marketing authorization for Wyost and Jubbonti in the EU	CF
05-22	Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars	MT

AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	05-08	MT
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	05-08	MT
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement	05-08	MT
Swiss Market Index Closes Higher; Sandoz Gains	05-08	MT
SANDOZ : Sandoz’s improvements are worth betting on	05-08
SANDOZ : Q1 miss not a worry; expect another boost for the share price	05-07
Sandoz: 5% sales growth in Q1	05-07	CF
Sandoz Group Logs Growth in Q1 Net Sales, Affirms FY24 Outlook	05-07	MT
Sandoz Group Ag Reiterates Earnings Guidance for the Full Year 2024	05-07	CI
Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla...	04-30
Sandoz Group AG Approves Dividend, Payable on May 7, 2024	04-30	CI
Sandoz Reaches Agreement With Amgen Resolving All Patent Litigation	04-30	DJ
Sandoz Group Settles Patent Disputes with Amgen	04-30	MT
Sandoz reaches agreement with Amgen over patent dispute	04-30	RE
Cigna to offer Humira rivals with $0 copay at specialty pharmacy	04-25	RE
Sandoz Confirms European Commission Approval of Pyzchiva® (ustekinumab), Further Strengthening Immunology Offering	04-22	CI
Bausch wins US appeal to block Alvogen generic of diarrhea drug	04-11	RE
Sandoz: new production site in Kundl	03-21	CF
Sandoz Launches New Antibiotic Production Plant in Kundl, Austria	03-21	MT
Sandoz Group Opens New Antibiotic Production Facility in Kundl, Austria	03-21	MT

No results for this search

SANDOZ : Sandoz’s improvements are worth betting on

May 08, 2024 at 08:08 am